microRNAs as the biomarkers of chemotherapy-induced peripheral neuropathy in patients with multiple myeloma
K Łuczkowska, D Rogińska, Z Ulańczyk… - Leukemia & …, 2021 - Taylor & Francis
Multiple myeloma (MM) is a malignant, incurable neoplastic disease. The currently used
treatment significantly improves the prognosis and extends the survival time of patients …
treatment significantly improves the prognosis and extends the survival time of patients …
microRNAs as the biomarkers of chemotherapy-induced peripheral neuropathy in patients with multiple myeloma.
K Łuczkowska, D Rogińska, Z Ulańczyk… - Leukemia & …, 2021 - search.ebscohost.com
Multiple myeloma (MM) is a malignant, incurable neoplastic disease. The currently used
treatment significantly improves the prognosis and extends the survival time of patients …
treatment significantly improves the prognosis and extends the survival time of patients …
microRNAs as the biomarkers of chemotherapy-induced peripheral neuropathy in patients with multiple myeloma
K Łuczkowska, D Rogińska… - Leukemia & …, 2021 - pubmed.ncbi.nlm.nih.gov
Multiple myeloma (MM) is a malignant, incurable neoplastic disease. The currently used
treatment significantly improves the prognosis and extends the survival time of patients …
treatment significantly improves the prognosis and extends the survival time of patients …
microRNAs as the biomarkers of chemotherapy-induced peripheral neuropathy in patients with multiple myeloma.
K Łuczkowska, D Rogińska, Z Ulańczyk… - Leukemia & …, 2021 - europepmc.org
Multiple myeloma (MM) is a malignant, incurable neoplastic disease. The currently used
treatment significantly improves the prognosis and extends the survival time of patients …
treatment significantly improves the prognosis and extends the survival time of patients …